Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
LGI Homes Opens New Community in Riverside
-
CorVista Health Announces Leadership Succession, Appointing Adrian Lam as President and CEO
-
Former Assistant U.S. Attorney Michele A. Ratcliffe to Join Oberheiden P.C.
-
JumpCloud Eliminates Shadow IT Threats With New SaaS Management Solution
-
Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
-
Greenridge Exploration and Ya’thi Néné Lands and Resources Announce Exploration Agreement in the Athabasca Region
-
BOS to Present at the Emerging Growth Conference on February 18, 2025
-
Genius Group calls EGM to approve share buyback, cancels rights offering.
-
Absorb Software Announces Record Growth and Groundbreaking Innovations, Redefining the Future of Learning Technology
-
Alliance Entertainment Unveils New Handmade by Robots Collectible Figures at Walmart, Tapping into the Booming Pop Culture Market
-
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based
-
Apollo Funds Acquire Bold Production Services, a Leading Provider of Production-Linked Contracted Gas Treatment Solutions
-
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
-
Applied Digital Closes $375 Million Financing with SMBC to Support Ellendale HPC Campus
-
NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease
-
KALA BIO Announces Chief Executive Officer Transition
-
PharmaTher Provides Update on FDA New Drug Application for Ketamine
-
Acres.com Welcomes Former Google Executive Matthieu Pellerin to Board of Directors
-
Horizon Aircraft Bolsters Cavorite X7 Development with Top Propulsion Expert
-
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
-
Willis appoints Guy Donahue as Cross Industry Midwest Property Broking Leader
-
Study Demonstrates the Clinical Value of Dynamic Digital Radiography to Quantitatively Diagnose Diaphragm Dysfunction
-
Honda Marine Enhances High-Power Outboards
-
Photronics to Report First Quarter Earnings
-
T-knife Therapeutics to Participate in Two Investor Conferences in March
-
Fujifilm and EndoSim Partner to Expand Access to Advanced Endoscopy Training
-
Acronis H2 2024 Cyberthreats Report Unveils Rise in Ransomware, AI-Driven Attacks, and Malware Risks
-
The Vita Coco Company to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
-
Inuvo Launches Self-Serve IntentKey Platform: A Revolutionary Interface for AI-Powered Audience Modeling
-
BigCommerce Strengthens Leadership Team with New Chief Revenue and Chief Marketing Officers
-
HII to Participate in Citi’s 2025 Global Industrial Tech and Mobility Conference on Feb. 18
-
Sunrise Realty Trust Schedules Earnings Release and Conference Call for the Fourth Quarter and Full Year Ending December 31, 2024
-
DICKEY-john Partners with GrainSense to Launch White Label Product Line
-
Advanced Flower Capital Schedules Earnings Release and Conference Call for the Fourth Quarter and Full Year Ending December 31, 2024
-
New Survey: Physicians Say PAs Expand Access to Care and Removing Barriers Would Reduce Wait Times and Provider Shortages
-
Intermex to Release Fourth Quarter and Full Year 2024 Earnings
-
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time
-
Uni-Fuels Awarded International Sustainability and Carbon Certifications, Reinforcing Commitment to Sustainable Marine Fuel Trading
-
Kalmar’s Board of Directors has decided on share-based payments related to long-term incentive plans
-
QDVI Launches Blockchain Real Estate with Tokenized Luxury Properties
-
SalMar - Invitation to presentation of the fourth quarter 2024 results
-
Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related
-
Xilio Therapeutics Announces Multiple Masked T Cell Engager Programs
-
P10 Reports Fourth Quarter and Full Year 2024 Earnings Results
-
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
-
American Tungsten Corp. Acquires Additional Claims Surrounding the IMA Mine in Idaho
-
Eminent Closes Acquisition of Celts Project in Nevada
-
AYR Cannabis Dispensary Updates Retail Footprint
-
UNISYNC Reports Improved Q1 Fiscal 2025 Operating Performance
-
Optiva Launches Agentic AI for Telecom BSS, Powered by Google’s Gemini Models
